Metabolic optimization: Combining prescription weight loss tools with 24/7 data from a glucose biosensor and Registered Dietitian support helps ensure sustainable results
When I went in there for the test, it was bad
The Hormonal Connection Emerging research suggests that hormonal status may influence how individuals respond to GLP-1 therapy, even at microdose levels
Semaglutide products include Ozempic, Rybelsus, Wegovy, and Wegovy HD, while tirzepatide products include Mounjaro and Zepbound
Shotsy does not provide medical advice, diagnosis, or treatment, and tracking should support care rather than replace it
Type 2 diabetes mellitus (DM2) affects a 13.8% of the Spanish population1 and its prevalence is expected to increase in the future.2 The presence of DM2 increases significantly the risk of cardiovascular events, chronic kidney disease (CKD), and premature death3,4 and as its prevalence increases it is expected to rise the incidence of microvascular and macrovascular complications.5 Until the last decade, the control of blood glucose, blood pressure, dyslipidemia, and the use of inhibitors of the renin-angiotensin system (iSRA) have been the only strategies available to reduce cardiovascular and renal risk in this population